Sign In
Buy EW
$87.45
+1.45 (+1.69%)
At Close: Jun 04, 2026
Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
Edwards Lifesciences Corporation (EW) Q3 2024 Earnings Call Transcript
09:30pm, Thursday, 24'th Oct 2024
Edwards Lifesciences Corporation (NYSE:EW ) Q3 2024 Earnings Conference Call October 24, 2024 5:30 PM ET Corporate Participants Mark Wilterding - Senior Vice President & Investor Relations Bernard Zov
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
09:15pm, Thursday, 24'th Oct 2024
LOS ANGELES , Oct. 24, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against
Compared to Estimates, Edwards Lifesciences (EW) Q3 Earnings: A Look at Key Metrics
07:01pm, Thursday, 24'th Oct 2024
Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare wi
EW Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges EW Investors with Losses to Contact the Firm
05:55pm, Thursday, 24'th Oct 2024
RADNOR, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United
Edwards Reverses Course, Falling On A Mixed Third-Quarter Report
05:11pm, Thursday, 24'th Oct 2024
Edwards Lifesciences stock briefly popped — and then slipped — on its mixed third-quarter report after wrapping up a key divestiture.
NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6,
Edwards Lifesciences Reports Third Quarter Results
04:21pm, Thursday, 24'th Oct 2024
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Sept. 30, 2024. Highlights and Outlook Q3 sales from continuing operations grew
NEW YORK, NY / ACCESSWIRE / October 24, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and cer
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman
01:36pm, Thursday, 24'th Oct 2024
SAN FRANCISCO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb.
EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
11:55am, Thursday, 24'th Oct 2024
SAN DIEGO, CA / ACCESSWIRE / October 24, 2024 / The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE:EW) securities between
NEWTOWN, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a leading class action law firm, announces the filing of a securities fraud class action on behalf of all purchasers of Edwards Li
SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired Edwards Life Sciences Corporation. (NYSE: E
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
04:00pm, Wednesday, 23'rd Oct 2024
/ ACCESSWIRE / October 23, 2024 / NEW YORK, NY / ACCESSWIRE / October 23, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potentia
NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and cer
